Finally, cDC1 cells from IBM patients expressed higher levels of the co-stimulatory gene CD40, the co-inhibitory gene HAVCR2, seven HLA genes, as well as IL15 than those from non-IBM patients, representing the most substantial activation among mDC subsets (Extended Data Table 1). This evidence concerns the gene HAVCR2 and inclusion body myositis.